Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2010; 55:538-542, doi:10.1016/j.jacc.2009.08.069
© 2010 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenkins, J. S.
Right arrow Articles by Ramee, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenkins, J. S.
Right arrow Articles by Ramee, S. R.
Related Collections
Right arrowRelated Articles

Endovascular Stenting for Vertebral Artery Stenosis

J. Stephen Jenkins, MD*, Samir N. Patel, MD, Christopher J. White, MD, Tyrone J. Collins, MD, John P. Reilly, MD, Paul W. McMullan, MD, Mark A. Grise, MD, Arthur G. Grant, MD and Stephen R. Ramee, MD

John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, Louisiana


Figure 1
View larger version (10K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Overall Survival

With the Kaplan-Meier Product Limit method, median survival is 10.1 years (121 months) with August 15, 2007, as the censoring date. Of 105 patients, 72.5% were censored and 30 (28.6%) died.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement